CNC.NYSECentene CORP

Form 4: Centene Director Monte E. Ford Reports Acquisition of Restricted Stock Units and Power of Attorney Update

Sentiment:

SEC Form 4 Filing


Director Monte E. Ford reports acquisition of restricted stock units in Centene Corporation and updates power of attorney for SEC filings.

Summary

  • On May 14, 2024, Monte E. Ford, a director of Centene Corp, acquired 2,916 shares of common stock.
  • These shares were received as restricted stock units, vesting fully on the earlier of May 14, 2025, or the date of the next annual stockholder meeting.
  • Following this transaction, Ford directly owns 7,255.771 shares of Centene Corp common stock.
  • Ford also holds options to purchase 10,000 shares of common stock at an exercise price of $86.49, exercisable from December 9, 2025, and expiring on December 9, 2032.
  • Additionally, Monte E. Ford updated his power of attorney on May 29, 2023, to allow Christopher A. Koster, Kendra Archer, Kate N. Casso, and Rebecca Scott to file SEC forms on his behalf.

Sentiment

Score: 6

Explanation: The document reflects standard insider transaction reporting and power of attorney updates, indicating neutral sentiment. The acquisition of restricted stock units is generally a positive sign, aligning director interests with shareholders, but it's a routine event.

Positives

  • The acquisition of restricted stock units aligns the director's interests with those of the shareholders.
  • The updated power of attorney ensures timely and accurate filing of SEC forms.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's future performance.

Industry Context

This filing is a routine disclosure related to insider transactions and is a standard practice for publicly traded companies. It provides transparency regarding the holdings and transactions of company directors.

Comparison to Industry Standards

  • Director stock ownership is common across publicly traded companies like UnitedHealth Group (UNH), Anthem (now Elevance Health, ELV), and Cigna (CI).
  • The vesting schedule of the restricted stock units is typical, often tied to continued service or performance milestones.
  • Power of attorney arrangements for SEC filings are standard practice to ensure compliance and efficiency.

Stakeholder Impact

  • Shareholders may view the acquisition of restricted stock units by a director as a positive sign, aligning management's interests with their own.
  • The updated power of attorney ensures continued compliance with SEC regulations.

Key Dates

DateDescription
May 29, 2023Date of the Limited Power of Attorney execution.
May 14, 2024Date of transaction: Acquisition of restricted stock units.
May 14, 2025Vesting date of restricted stock units (or earlier if next annual meeting occurs sooner).
December 09, 2025Earliest exercisable date for common stock options.
December 09, 2032Expiration date for common stock options.
May 15, 2024Date of signature for the SEC filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.